Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Drug activity screening based on microsomes-hydrogel system in predicting metabolism induced antitumor effect of oroxylin A.

Yang H, Li J, Zheng Y, Zhou L, Tong S, Zhao B, Cai W.

Sci Rep. 2016 Feb 24;6:21604. doi: 10.1038/srep21604.

2.

Identification and validation of genetic variants that influence transcription factor and cell signaling protein levels.

Hause RJ, Stark AL, Antao NN, Gorsic LK, Chung SH, Brown CD, Wong SS, Gill DF, Myers JL, To LA, White KP, Dolan ME, Jones RB.

Am J Hum Genet. 2014 Aug 7;95(2):194-208. doi: 10.1016/j.ajhg.2014.07.005. Epub 2014 Jul 31.

3.

Genome-wide hypermethylation coupled with promoter hypomethylation in the chorioamniotic membranes of early onset pre-eclampsia.

Ching T, Song MA, Tiirikainen M, Molnar J, Berry M, Towner D, Garmire LX.

Mol Hum Reprod. 2014 Sep;20(9):885-904. doi: 10.1093/molehr/gau046. Epub 2014 Jun 18.

4.

Dido3-dependent HDAC6 targeting controls cilium size.

Sánchez de Diego A, Alonso Guerrero A, Martínez-A C, van Wely KH.

Nat Commun. 2014 Mar 25;5:3500. doi: 10.1038/ncomms4500.

5.

Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness.

Jami MS, Hou J, Liu M, Varney ML, Hassan H, Dong J, Geng L, Wang J, Yu F, Huang X, Peng H, Fu K, Li Y, Singh RK, Ding SJ.

BMC Cancer. 2014 Mar 15;14:194. doi: 10.1186/1471-2407-14-194.

6.

The death-inducer obliterator 1 (Dido1) gene regulates embryonic stem cell self-renewal.

Liu Y, Kim H, Liang J, Lu W, Ouyang B, Liu D, Songyang Z.

J Biol Chem. 2014 Feb 21;289(8):4778-86. doi: 10.1074/jbc.M113.486290. Epub 2013 Dec 17.

7.

Differential gene expression analysis in k562 human leukemia cell line treated with benzene.

Choi S, Kim JY, Moon JD, Baek HJ, Kook H, Seo SB.

Toxicol Res. 2011 Mar;27(1):43-8. doi: 10.5487/TR.2011.27.1.043.

8.

Structural mimicry in transcription regulation of human RNA polymerase II by the DNA helicase RECQL5.

Kassube SA, Jinek M, Fang J, Tsutakawa S, Nogales E.

Nat Struct Mol Biol. 2013 Jul;20(7):892-9. doi: 10.1038/nsmb.2596. Epub 2013 Jun 9.

9.

New targets for the antitumor activity of gambogic acid in hematologic malignancies.

Yang LJ, Chen Y.

Acta Pharmacol Sin. 2013 Feb;34(2):191-8. doi: 10.1038/aps.2012.163. Epub 2012 Dec 31. Review.

10.

Ablation of Dido3 compromises lineage commitment of stem cells in vitro and during early embryonic development.

Fütterer A, Raya A, Llorente M, Izpisúa-Belmonte JC, de la Pompa JL, Klatt P, Martínez-A C.

Cell Death Differ. 2012 Jan;19(1):132-43. doi: 10.1038/cdd.2011.62. Epub 2011 Jun 10.

11.

Dido disruption leads to centrosome amplification and mitotic checkpoint defects compromising chromosome stability.

Trachana V, van Wely KH, Guerrero AA, Fütterer A, Martínez-A C.

Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2691-6. Epub 2007 Feb 13.

12.

Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms.

Fütterer A, Campanero MR, Leonardo E, Criado LM, Flores JM, Hernández JM, San Miguel JF, Martínez-A C.

J Clin Invest. 2005 Sep;115(9):2351-62. Epub 2005 Aug 25.

13.

SPOC: a widely distributed domain associated with cancer, apoptosis and transcription.

Sánchez-Pulido L, Rojas AM, van Wely KH, Martinez-A C, Valencia A.

BMC Bioinformatics. 2004 Jul 7;5:91.

14.

Identification of p53 regulators by genome-wide functional analysis.

Huang Q, Raya A, DeJesus P, Chao SH, Quon KC, Caldwell JS, Chanda SK, Izpisua-Belmonte JC, Schultz PG.

Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3456-61. Epub 2004 Feb 27.

15.
16.

Death inducer-obliterator 1 triggers apoptosis after nuclear translocation and caspase upregulation.

García-Domingo D, Ramírez D, González de Buitrago G, Martínez-A C.

Mol Cell Biol. 2003 May;23(9):3216-25.

Supplemental Content

Support Center